Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Yisheng Biopharma releases phase I topline results for PIKA rabies vaccine

Jan. 5, 2016

Matinas BioPharma files IND application with FDA for MAT-2501

Jan. 5, 2016

Arbutus initiates phase IIa study of ARB-001467 for chronic HBV

Jan. 5, 2016

Gilead Sciences studies ledipasvir/sofosbuvir for chronic HCV and HBV coinfection

Jan. 4, 2016

Bristol-Myers Squibb reports development of NS5B inhibitors

Dec. 31, 2015

Shionogi reports development of antifungal agents

Dec. 30, 2015

Chinese team develops S. aureus golden pigment synthesis inhibitors

Dec. 29, 2015

SK Chemicals' SKY Cellflu Quadrivalent approved in South Korea

Dec. 29, 2015

Primary endpoint not met in Chimerix's phase III SUPPRESS trial of brincidofovir

Dec. 29, 2015

WHO to review Emergency Use Assessment and Listing application for Merck & Co. Ebola vaccine

Dec. 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...